ArticleRadiation oncology (London, England)2022

Phase I trial of hypofractionated chemoradiotherapy in the palliative management of esophageal and gastro-esophageal cancer.

Swetha Sridharan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.